Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats

Table 4

Effects of pioglitazone, RUZU, and fenofibrate on the liver index in the experimental groups.

Groups	Normal	PIO	RUZU	NAFLD	FENO
Liver index (%)	3.07 ± 0.03^b	4.58 ± 0.05^ab	3.93 ± 0.04^ab	6.55 ± 0.30^a	4.94 ± 0.06^ab

Values are presented as mean ± SEM (n = 5)., a significant difference compared to normal control. , a significant difference compared to the NAFLD group. NAFLD: nonalcoholic fatty liver disease, PIO: pioglitazone (4 mg/kg body weight), RUZU: Ruzu herbal bitters (0.6 mg/kg body weight), and FENO: fenofibrate (10 mg/kg body weight).